Geneos Wealth Management’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Other funds holding STAA
BC
PAI
GCM
EFM
Geneos Wealth Management's STAA Position: Q3 2022 in Review
Geneos Wealth Management sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 100 shares — an estimated $7K sold.
Geneos Wealth Management first reported a position in STAA in Q1 2021 and held it in 5 quarters. The position peaked at $12K in Q3 2021. 304 funds tracked by Wall St. Rank hold STAA as of Q3 2022.
- Geneos Wealth Management reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
- Geneos Wealth Management sold 100 STAAR Surgical shares in Q3 2022, an estimated $7K.
- Geneos Wealth Management first reported a position in STAAR Surgical in Q1 2021 and held it in 5 quarters.
- Geneos Wealth Management's STAAR Surgical position peaked at $12K in Q3 2021.
- 304 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.
Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.